https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct05996523-2026-06-23 Hipa.ai en 2026-06-23T00:00:00.000Z Pembrolizumab + PRGN-2009 for HPV-Oropharyngeal Cancer: 93.8% T-cell Increase https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct04740307-2026-06-23 Hipa.ai en 2026-06-23T00:00:00.000Z Pembrolizumab/Quavonlimab + Lenvatinib Shows 21.0-Month OS in Advanced HCC https://hipa.ai/drug/adalimumab/updates/trial-results-posted-nct03759288-2026-06-23 Hipa.ai en 2026-06-23T00:00:00.000Z Adalimumab Comparator Trial for Crohn's Disease Posts Brazikumab PK Data https://hipa.ai/drug/empagliflozin/updates/trial-results-posted-nct06287073-2026-06-23 Hipa.ai en 2026-06-23T00:00:00.000Z Jardiance Post-Marketing Study in Korean CKD Patients Details Safety & UACR… https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct04929392-2026-06-23 Hipa.ai en 2026-06-23T00:00:00.000Z Pembrolizumab Combination Trial Shows No Complete Responses in Esophageal Cancer https://hipa.ai/drug/guselkumab/updates/trial-results-posted-nct04645355-2026-06-23 Hipa.ai en 2026-06-23T00:00:00.000Z Guselkumab Alters CD4+ and CD8+ T-Cell Levels in Psoriasis Study https://hipa.ai/drug/canagliflozin/updates/boxed-warning-present-label-metformin-hydrochloride-label-2026-06-19 Hipa.ai en 2026-06-19T00:00:00.000Z Metformin Hydrochloride Label Adds Boxed Warning for Lactic Acidosis https://hipa.ai/drug/canagliflozin/updates/boxed-warning-revised-metformin-hydrochloride-label-2026-06-19 Hipa.ai en 2026-06-19T00:00:00.000Z Metformin Hydrochloride Boxed Warning Revised for Lactic Acidosis https://hipa.ai/drug/canagliflozin/updates/boxed-warning-present-label-metformin-hydrochloride-label-2026-06-18 Hipa.ai en 2026-06-18T00:00:00.000Z Metformin Hydrochloride Label Adds Boxed Warning for Lactic Acidosis https://hipa.ai/drug/canagliflozin/updates/boxed-warning-revised-metformin-hydrochloride-label-2026-06-18 Hipa.ai en 2026-06-18T00:00:00.000Z Metformin Hydrochloride Label Revised: Boxed Warning Added for Lactic Acidosis